undefined cover
undefined cover
From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird cover
From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird cover
Science For Care

From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird

From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird

33min |24/06/2025
Play
undefined cover
undefined cover
From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird cover
From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird cover
Science For Care

From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird

From Vision to Market: Navigating HealthTech with Tilak and Bird & Bird

33min |24/06/2025
Play

Description

New Podcast Episode! 🎙️

For the second episode of this brand-new season, we had the pleasure of hosting
Caroline Arrighi-Savoie, Senior Associate - Healthcare & Life Sciences at Bird & Bird France and one of Bird & Bird’s clients, Edouard Gasser, CEO and co-founder of Tilak Healthcare.


They will discuss:

-       How Tilak's innovative product, Odysight, changes the game by combining remote monitoring of visual parameters with a fun patient experience powered by video games

-       How to overcome business and regulatory challenges (securing funding, clinical validation, regulatory pathway, market access, etc.) to reach commercial maturity for an innovative healthcare company as Tilak

-       How partnering with Bird & Bird lawyers on legal but also business aspects helped Tilak meet these challenges and build their competitive edge in the market

-       How different innovative healthcare products regulatory regimes may impact your go-to-market strategy

-       Practical advice for entrepreneurs in an highly regulated healthtech sector

🔊
Listen now!

Let us know your thoughts in the comments!


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Description

New Podcast Episode! 🎙️

For the second episode of this brand-new season, we had the pleasure of hosting
Caroline Arrighi-Savoie, Senior Associate - Healthcare & Life Sciences at Bird & Bird France and one of Bird & Bird’s clients, Edouard Gasser, CEO and co-founder of Tilak Healthcare.


They will discuss:

-       How Tilak's innovative product, Odysight, changes the game by combining remote monitoring of visual parameters with a fun patient experience powered by video games

-       How to overcome business and regulatory challenges (securing funding, clinical validation, regulatory pathway, market access, etc.) to reach commercial maturity for an innovative healthcare company as Tilak

-       How partnering with Bird & Bird lawyers on legal but also business aspects helped Tilak meet these challenges and build their competitive edge in the market

-       How different innovative healthcare products regulatory regimes may impact your go-to-market strategy

-       Practical advice for entrepreneurs in an highly regulated healthtech sector

🔊
Listen now!

Let us know your thoughts in the comments!


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Share

Embed

You may also like

Description

New Podcast Episode! 🎙️

For the second episode of this brand-new season, we had the pleasure of hosting
Caroline Arrighi-Savoie, Senior Associate - Healthcare & Life Sciences at Bird & Bird France and one of Bird & Bird’s clients, Edouard Gasser, CEO and co-founder of Tilak Healthcare.


They will discuss:

-       How Tilak's innovative product, Odysight, changes the game by combining remote monitoring of visual parameters with a fun patient experience powered by video games

-       How to overcome business and regulatory challenges (securing funding, clinical validation, regulatory pathway, market access, etc.) to reach commercial maturity for an innovative healthcare company as Tilak

-       How partnering with Bird & Bird lawyers on legal but also business aspects helped Tilak meet these challenges and build their competitive edge in the market

-       How different innovative healthcare products regulatory regimes may impact your go-to-market strategy

-       Practical advice for entrepreneurs in an highly regulated healthtech sector

🔊
Listen now!

Let us know your thoughts in the comments!


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Description

New Podcast Episode! 🎙️

For the second episode of this brand-new season, we had the pleasure of hosting
Caroline Arrighi-Savoie, Senior Associate - Healthcare & Life Sciences at Bird & Bird France and one of Bird & Bird’s clients, Edouard Gasser, CEO and co-founder of Tilak Healthcare.


They will discuss:

-       How Tilak's innovative product, Odysight, changes the game by combining remote monitoring of visual parameters with a fun patient experience powered by video games

-       How to overcome business and regulatory challenges (securing funding, clinical validation, regulatory pathway, market access, etc.) to reach commercial maturity for an innovative healthcare company as Tilak

-       How partnering with Bird & Bird lawyers on legal but also business aspects helped Tilak meet these challenges and build their competitive edge in the market

-       How different innovative healthcare products regulatory regimes may impact your go-to-market strategy

-       Practical advice for entrepreneurs in an highly regulated healthtech sector

🔊
Listen now!

Let us know your thoughts in the comments!


Hosted by Ausha. See ausha.co/privacy-policy for more information.

Share

Embed

You may also like